GO:0000122 |
P |
negative regulation of transcription by RNA polymerase II |
GO:0001078 |
F |
DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO:0001102 |
F |
RNA polymerase II-specific DNA-binding transcription factor binding |
GO:0002805 |
P |
regulation of antimicrobial peptide biosynthetic process |
GO:0003677 |
F |
DNA binding |
GO:0005515 |
F |
protein binding |
GO:0005634 |
C |
nucleus |
GO:0006351 |
P |
transcription, DNA-templated |
GO:0006355 |
P |
regulation of transcription, DNA-templated |
GO:0007362 |
P |
terminal region determination |
GO:0007390 |
P |
germ-band shortening |
GO:0007391 |
P |
dorsal closure |
GO:0007393 |
P |
dorsal closure, leading edge cell fate determination |
GO:0007398 |
P |
ectoderm development |
GO:0007507 |
P |
heart development |
GO:0008134 |
F |
transcription factor binding |
GO:0008258 |
P |
head involution |
GO:0008293 |
P |
torso signaling pathway |
GO:0009996 |
P |
negative regulation of cell fate specification |
GO:0022416 |
P |
chaeta development |
GO:0030097 |
P |
hemopoiesis |
GO:0035167 |
P |
larval lymph gland hemopoiesis |
GO:0042440 |
P |
pigment metabolic process |
GO:0042690 |
P |
negative regulation of crystal cell differentiation |
GO:0043433 |
P |
negative regulation of DNA-binding transcription factor activity |
GO:0046665 |
P |
amnioserosa maintenance |
GO:0046872 |
F |
metal ion binding |
GO:0048542 |
P |
lymph gland development |
GO:0048749 |
P |
compound eye development |